Saddam Mansuri, a father of two, holds up bottles of Coldrif and Relife cough syrup in Parasia, Madhya Pradesh, India, on October 10, 2025. Priyanshu Singh/Reuters New Delhi —

The World Health Organization (WHO) on Monday issued a health advisory warning against the use and distribution of three cough syrups believed to be responsible for the deaths of several children in India over the last month.

The drugs were identified as specific batches of Coldrif, Respifresh TR and ReLife, the WHO said in a statement , manufactured by three Indian companies: Sresan Pharmaceutical, Rednex Pharmaceuticals, and Shape Pharma.

The oral liquid drugs were found to contain higher levels of diethylene glycol (DEG), a toxic ingredient that can lead to serious injury or death, especially in childr

See Full Page